optic neuritis glp 1 Anterior ischemic neuropathy in patients treated with semaglutide: report of four cases with a possible association | BMC Ophthalmology GLP-1 Medications and NAION: What

doi: 10.1021/js980042+

Understanding GLP-1 Receptor Agonists GLP-1 receptor agonists have revolutionized the treatment of Type 2 diabetes and obesity by mimicking the effects of the natural hormone GLP-1

[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Kim D, MacConell L, Zhuang D, Kothare PA, Trautmann M, Fineman M, et al

With updated clinical guideline recommendations and changes to drug labeling in 20202022, as well as the 2021 approval of finerenonethe only new drug indicated for CKD associated with type 2 diabetes approved in this time periodit is of interest to understand how patterns of SGLT2i and GLP-1 RA use and characteristics of patients prescribed these medications in the US may have changed